Smith & Nephew PLC (NYSE:SNN) Passes the Caviar Cruise Screen for Quality Investing

By – Last update:

Quotes Stocks Mentioned

Article Mentions:

For investors looking to assemble a portfolio of durable, high-grade businesses, the ideas of quality investing offer a useful structure. This method concentrates on finding companies with lasting competitive strengths, sound financial condition, and the capacity to produce steady, high returns on capital over many years. One orderly way to find these companies is the "Caviar Cruise" stock screen, which uses a set of strict, measurable filters to separate firms with better past results and solid financial traits. The screen stresses measures like continued revenue and profit increase, high returns on invested capital, good free cash flow production, and a reasonable debt level.

Smith & Nephew PLC - Spon ADR (NYSE:SNN)

A recent use of this screen has brought attention to Smith & Nephew PLC - Spon ADR (NYSE:SNN), a worldwide medical technology company. A detailed look shows how SNN matches the central beliefs of the quality investing view as set by the Caviar Cruise system.

Match with Caviar Cruise Standards

The Caviar Cruise screen applies particular financial limits to find quality. Smith & Nephew's operational and financial history shows a good match with these important filters:

  • Continued Increase: The screen needs at least a 5% compound annual growth rate (CAGR) for both revenue and EBIT (earnings before interest and taxes) over five years. SNN easily passes both limits, with a revenue CAGR of 6.07% and a more notable EBIT CAGR of 15.12%. Importantly, EBIT increase surpassing revenue increase—as seen here—is a sign of operational effectiveness and possible pricing strength, showing the company is growing more profitable as it gets larger.

  • Outstanding Capital Effectiveness: A central part of quality investing is a high return on invested capital (ROIC), which gauges how well a company creates profits from its capital base. The Caviar Cruise screen sets a high level at 15% for ROIC leaving out cash, goodwill, and intangibles. SNN's number of 19.18% not only meets but clearly passes this need, implying the company has strong competitive barriers and uses shareholder capital very well.

  • Good Financial Condition and Cash Flow: Quality companies are not just profitable but also financially stable and produce cash. The screen checks this by examining the Debt-to-Free Cash Flow ratio (favoring a number under 5) and Profit Quality (the part of net income changed to free cash flow, with a goal above 75%).

    • SNN's Debt/FCF ratio of 3.90 shows it could pay off all its debt with under four years of current free cash flow, indicating a sound and workable balance sheet.
    • Possibly more significant is its five-year average Profit Quality of 98.21%. This almost complete change rate means nearly all its accounting profits become real, usable cash—a main sign of earnings strength and financial toughness.

Basic Profile Summary

A look at Smith & Nephew's wider basic analysis report supports the image shown by the screen-specific measures. The company gets a firm total score, with specific strong points in profitability. Its margins are solid next to industry competitors, and it shows a regular history of profit and positive cash flow production. While increase rates are moderate, they are stable and likely to persist. The price seems fair next to both the market and its industry, especially when looking at measures like Price-to-Free Cash Flow. For a complete outline, you can see the full basic analysis report for SNN.

Investment Points

For the quality investor, Smith & Nephew offers a case based on steadiness and reliable performance. The company works in the necessary healthcare field, supplying medical devices for orthopedics, sports medicine, and wound care—areas with long-run, population-led need. Its global presence and group of known products add to the lasting revenue flows that quality investors look for. The financial measures highlighted by the Caviar Cruise screen—outstanding ROIC, high cash change, and careful debt handling—imply a business model made for endurance instead of short-term chance.

It is key to remember that the Caviar Cruise screen is a beginning for more study. While it successfully finds companies with excellent numerical features, the non-numerical parts of quality investing—like deep competitive edges, skilled leadership, and contact to long-run structural trends—need more investor careful examination.

Finding Other Quality Possibilities

Smith & Nephew is one instance found through a strict screening process. Investors curious about using the same exact standards to the wider market can use the Caviar Cruise stock screener to search for other possible candidates that meet these high marks for quality.

Disclaimer: This article is for information only and does not make financial guidance, a support, or a suggestion to buy, sell, or keep any security. Investing includes risk, including the possible loss of original money. You should do your own study and talk with a skilled financial consultant before making any investment choices.